These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2080069)

  • 21. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group.
    Blondeau JM; Yaschuk Y; Suter M; Vaughan D
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():3-23. PubMed ID: 10225567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance in human chronic periodontitis microbiota.
    Rams TE; Degener JE; van Winkelhoff AJ
    J Periodontol; 2014 Jan; 85(1):160-9. PubMed ID: 23688097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).
    Jones RN; Pfaller MA;
    Diagn Microbiol Infect Dis; 2001 Apr; 39(4):237-43. PubMed ID: 11404067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
    Madhusudhan KT; Counts C; Lody C; Carter O; Dodson S; Ojha N
    Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.
    Lee RA; Scully MC; Camins BC; Griffin RL; Kunz DF; Moser SA; Hoesley CJ; McCarty TP; Pappas PG
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1419-1424. PubMed ID: 30296959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme(GNSOP) Annual Report 2015.
    Bell JM; Gottlieb T; Daley DA; Coombs GW;
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2016.
    Bell JM; Gottlieb T; Daley DA; Coombs GW
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetracycline-resistant micro-organisms recovered from patients with refractory periodontal disease.
    Olsvik B; Hansen BF; Tenover FC; Olsen I
    J Clin Periodontol; 1995 May; 22(5):391-6. PubMed ID: 7601921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periodontal disease as reservoir for multi-resistant and hydrolytic enterobacterial species.
    Gonçalves MO; Coutinho-Filho WP; Pimenta FP; Pereira GA; Pereira JA; Mattos-Guaraldi AL; Hirata R
    Lett Appl Microbiol; 2007 May; 44(5):488-94. PubMed ID: 17451514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
    Toh HS; Chuang YC; Huang CC; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Ko WC; Yu KW; Liu YC; Chen YS; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S18-23. PubMed ID: 22749054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of 6 putative periodontal pathogens in subgingival plaque samples from Romanian adult periodontitis patients.
    Ali RW; Velcescu C; Jivanescu MC; Lofthus B; Skaug N
    J Clin Periodontol; 1996 Feb; 23(2):133-9. PubMed ID: 8849850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Gram-negative bacteria causing intra-abdominal infections in China: SMART China 2011.
    Zhang H; Yang Q; Xiao M; Chen M; Badal RE; Xu Y
    Chin Med J (Engl); 2014; 127(13):2429-33. PubMed ID: 24985578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain.
    van Winkelhoff AJ; Herrera D; Oteo A; Sanz M
    J Clin Periodontol; 2005 Aug; 32(8):893-8. PubMed ID: 15998275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro studies of ciprofloxacin and survey of resistance patterns in current isolates.
    Fernandes CJ; Ackerman VP
    Diagn Microbiol Infect Dis; 1990; 13(2):79-91. PubMed ID: 2369816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015.
    Coombs GW; Daley DA; Lee YT; Pang S; Bell JM; Turnidge JD;
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30632361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.
    Sahm DF; Critchley IA; Kelly LJ; Karlowsky JA; Mayfield DC; Thornsberry C; Mauriz YR; Kahn J
    Antimicrob Agents Chemother; 2001 Jan; 45(1):267-74. PubMed ID: 11120976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.